[ad_1]
A research group based in Israel claims to have a complete cure for cancer one year from now. But the experts are doubtful and with good reason.
THE QUESTION:
Is the claim of Accelerated Evolution Biotechnologies Ltd (AEBI) legitimate? Could they really have a cure for cancer in the year?
THE ANSWER:
The question here deserves a rare designation of VERIFY. This claim is INVERSIBLE.
In simple terms, there is not enough evidence to prove or disprove the statement. The experts who published their claims firmly declare that they will have a cure, but the experts with whom we spoke outside the AEBI were skeptical.
There is nothing wrong with staying optimistic about such an badertion, but that deserves a dose of skepticism.
WHAT WE HAVE FOUND:
Without going into too much scientific jargon, the AEBI claims to have found a way to directly target and eliminate cancer cells without harming surrounding healthy cells.
They claim to have identified a way to bind several "peptides" to a cancer cell and then destroy the peptide and the cell. For reference, peptides are molecular compounds composed of two or more amino acids.
In an interview with the "Jerusalem Post", the president of the AEBI said that he "believed that we would propose in a year a comprehensive treatment against cancer."
But unlike typical medical discoveries, the AEBI did not publish its findings in a medical journal. Instead, they published a "proof of concept" of about two pages identifying some of their test results.
According to a statement from Dr. Leonard Lichtenfeld, Acting Chief Medical Officer of the American Cancer Society, the lack of detailed publication is a sign of caution.
"It's a story based on limited information provided by researchers and a company working on this technology," he wrote in a blog post. "It has apparently not been published in the scientific literature where it could be subject to review, support and / or criticism from knowledgeable peers."
He added several "key points" explaining why the results should be viewed with a skeptical eye:
-
"My colleagues at the American Cancer Society tell me that presentation techniques using phages or peptides, although very powerful search tools for the selection of high-affinity binders, have had a difficult path as as potential drugs. If this group is just starting clinical trials, they may have difficult future experiences.
-
This is based on a mouse experiment that is described as "exploratory". It seems at this point that there is no well-established program of experiments to better define how it works – and perhaps it will not work – when it moves from the laboratory to the doctor's office.
-
We all hope to quickly find a cure for cancer. It is certainly possible that this approach is a job. However, as experience has taught us many times, the gap between a successful mouse experience and the effective and beneficial application of exciting laboratory concepts to help patients with Alzheimer's disease. from cancer to the bedside is actually a long and perilous journey fraught with unforeseen and unforeseen obstacles.
-
It may take some time to demonstrate the benefits of this new approach to cancer treatment. And unfortunately, based on other similar claims of advanced technologies for the treatment of cancer, there is a good chance that it will not succeed. "
In the absence of any concrete evidence or methodology, and the skepticism of experts from the American Cancer Society, the Verify team chooses a rare path and qualifies this statement as "unverified."
"We must be aware that this is far from being proven as an effective treatment for people with cancer," wrote Dr. Lichtenfeld, "not to mention a cure."
[ad_2]
Source link
